IJMS | Free Full-Text | Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
Figure 1 from Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level. | Semantic Scholar
The A3 Adenosine Receptor: History and Perspectives
IJMS | Free Full-Text | The Adenosine A3 Receptor Regulates Differentiation of Glioblastoma Stem-Like Cells to Endothelial Cells under Hypoxia
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?: Trends in Pharmacological Sciences
Cancer biology and molecular genetics of A3 adenosine receptor | Oncogene
2‑Cl‑IB‑MECA regulates the proliferative and drug resistance pathways, and facilitates chemosensitivity in pancreatic and
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?: Trends in Pharmacological Sciences
Molecules | Free Full-Text | Drugs Targeting the A3 Adenosine Receptor: Human Clinical Study Data
Blockade and absence of A 3 AR decreases cell differentiation of... | Download Scientific Diagram
Frontiers | CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
The A3 Adenosine Receptor: History and Perspectives | Pharmacological Reviews
Anticancer activity study of A3 adenosine receptor agonists - ScienceDirect
The A3 adenosine receptor (A3AR): therapeutic target and predictive biological marker in rheumatoid arthritis | SpringerLink
Drugs Targeting the A3 Adenosine Receptor: Human Clinical Study Data
A3 Adenosine Receptor: Pharmacology and Role in Disease | SpringerLink
Glioblastoma: Current Status, Emerging Targets, and Recent Advances | Journal of Medicinal Chemistry
IJMS | Free Full-Text | Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
Frontiers | Tumor Microenvironment Uses a Reversible Reprogramming of Mesenchymal Stromal Cells to Mediate Pro-tumorigenic Effects
Polypharmacology of N6-(3-Iodobenzyl)adenosine-5′-N-methyluronamide (IB-MECA) and Related A3 Adenosine Receptor Ligands: Peroxisome Proliferator Activated Receptor (PPAR) γ Partial Agonist and PPARδ Antagonist Activity Suggests Their Antidiabetic ...
ATP Promotes Oral Squamous Cell Carcinoma Cell Invasion and Migration by Activating the PI3K/AKT Pathway via the P2Y2-Src-EGFR Axis | ACS Omega
Cancer biology and molecular genetics of A3 adenosine receptor | Oncogene
Adenosine receptors and cancer - ScienceDirect
